|
ORIGINAL RESEARCH |
|
|
|
Year : 2011 |
Volume
: 22 | Issue : 5 | Page
: 639-643 |
|
Lycopene in the management of oral lichen planus: A placebo-controlled study
Nisheeth Saawarn1, MC Shashikanth2, Swati Saawarn3, Vasanti Jirge4, Nallan CSK Chaitanya5, R Pinakapani6
1 Department of Oral Medicine and Radiology, People's College of Dental Sciences and Research Centre, Bhopal, India 2 UP Dental College and Research Centre, Lucknow, India 3 Department of Oral Pathology and Microbiology, People's Dental Academy, Bhopal, India 4 Department of Oral Medicine and Radiology, KLE Institute of Dental Sciences, Belguam, India 5 Mamata Dental College and Hospital, Khammam, India 6 Genesis Institute of Dental Sciences and Research, Ferozpur, India
Correspondence Address:
Nisheeth Saawarn Department of Oral Medicine and Radiology, People's College of Dental Sciences and Research Centre, Bhopal India
 Source of Support: Study medications (Capsule Lycored & Identical Placebo) provided by Jagsonpal Pharmaceutical, New Delhi, India, Conflict of Interest: None  | Check |
DOI: 10.4103/0970-9290.93448
|
|
Context: Oxidative stress has been implicated in the pathogenesis of lichen planus, and a lower level of lycopene has been reported in erosive and atrophic oral lichen planus (OLP) patients. However, its efficacy in the management of OLP has not been reported.
Aim: This study was designed to assess the efficacy of systemic lycopene in the management of OLP.
Settings and Design: This prospective, randomized, double-blind, placebo-controlled study was done in the Oral Medicine Department of a postgraduate teaching dental hospital in India.
Materials and Methods: Thirty symptomatic OLP patients, randomly divided into two groups of 15 each, were administered lycopene 8 mg/day and an identical placebo, respectively, for 8 consecutive weeks. Burning sensation using visual analogue scale and overall treatment response using Tel Aviv-San Francisco scale were recorded at every visit. The data obtained were analyzed statistically using Wilcoxon Rank test, Mann-Whitney and Fischer's Exact test.
Results: A higher (84%) reduction in burning sensation was seen in lycopene than in the placebo group (67%). All 15 (100%) patients in the lycopene group showed 50% or more benefit and 11 (73.3%) patients showed 70-100% benefit, while this number was only 10 and 4 (26.7%), respectively, in the placebo group.
Conclusion: Lycopene was very effective in the management of OLP, and oxidative stress may have a role in disease pathogenesis. |
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|